Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-06-04 @ 7:34 AM
Study NCT ID:
NCT01406327
Status:
COMPLETED
Last Update Posted:
2020-09-03
First Post:
2011-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypertension, Pulmonary | View |
Keywords: